IRIS
SORMANI, MARIA PIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 48.263
AS - Asia 4.820
NA - Nord America 2.934
SA - Sud America 412
AF - Africa 87
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 2
Totale 56.527
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 47.441
US - Stati Uniti d'America 2.752
SG - Singapore 2.131
CN - Cina 1.209
VN - Vietnam 699
FR - Francia 410
BD - Bangladesh 268
BR - Brasile 265
HK - Hong Kong 175
DE - Germania 102
MX - Messico 71
FI - Finlandia 70
AR - Argentina 61
CA - Canada 57
IN - India 46
GB - Regno Unito 44
IQ - Iraq 41
JP - Giappone 39
CH - Svizzera 35
NL - Olanda 29
ZA - Sudafrica 26
RU - Federazione Russa 25
SA - Arabia Saudita 21
PK - Pakistan 19
EC - Ecuador 18
TH - Thailandia 18
VE - Venezuela 17
CL - Cile 16
ID - Indonesia 16
JM - Giamaica 16
TR - Turchia 15
CO - Colombia 14
ES - Italia 14
PH - Filippine 13
DZ - Algeria 12
KE - Kenya 12
UA - Ucraina 12
KR - Corea 11
MA - Marocco 10
TN - Tunisia 10
IE - Irlanda 9
NP - Nepal 9
AU - Australia 8
AZ - Azerbaigian 8
JO - Giordania 8
PE - Perù 8
AL - Albania 7
AT - Austria 7
MY - Malesia 7
TW - Taiwan 7
UZ - Uzbekistan 7
AE - Emirati Arabi Uniti 6
CR - Costa Rica 6
EG - Egitto 6
GT - Guatemala 6
HN - Honduras 6
KZ - Kazakistan 6
SE - Svezia 6
CZ - Repubblica Ceca 5
QA - Qatar 5
RS - Serbia 5
SY - Repubblica araba siriana 5
UY - Uruguay 5
BO - Bolivia 4
DO - Repubblica Dominicana 4
GR - Grecia 4
IL - Israele 4
IR - Iran 4
KH - Cambogia 4
PL - Polonia 4
RO - Romania 4
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
BH - Bahrain 3
BY - Bielorussia 3
KG - Kirghizistan 3
OM - Oman 3
PT - Portogallo 3
SI - Slovenia 3
BE - Belgio 2
EE - Estonia 2
GP - Guadalupe 2
HU - Ungheria 2
LB - Libano 2
MM - Myanmar 2
NI - Nicaragua 2
PA - Panama 2
PR - Porto Rico 2
PY - Paraguay 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BW - Botswana 1
CM - Camerun 1
CU - Cuba 1
CV - Capo Verde 1
CW - ???statistics.table.value.countryCode.CW??? 1
Totale 56.502
Salva come PNG Salva come JPEG
Città #
Genova 30.364
Genoa 10.417
Rapallo 3.390
Vado Ligure 2.824
San Jose 1.072
Singapore 970
Lauterbourg 387
Ashburn 368
Ho Chi Minh City 196
Beijing 184
Hong Kong 165
New York 161
Hanoi 149
Bordighera 104
Council Bluffs 96
Santa Clara 87
Frankfurt am Main 70
Helsinki 68
Los Angeles 46
Mexico City 44
Da Nang 36
Haiphong 35
Rome 32
Tokyo 31
Zurich 30
Milan 29
Tianjin 29
São Paulo 24
Buffalo 22
Phoenix 21
Chicago 20
Boardman 19
Naples 18
Toronto 17
Baghdad 16
Can Tho 15
Dallas 15
Guangzhou 15
Hải Dương 15
Johannesburg 14
San Francisco 14
Atlanta 12
Orem 12
Shanghai 12
St Louis 12
Amsterdam 11
Brooklyn 11
Cardiff 11
Nairobi 11
Des Moines 10
Houston 10
Nuremberg 10
Schiffdorf 10
Turin 10
Bangkok 9
Bari 9
Bologna 9
Florence 9
Kingston 9
Riyadh 9
Santiago 9
Amman 8
Baku 8
Montreal 8
Rio de Janeiro 8
Biên Hòa 7
Charlotte 7
Columbus 7
Denver 7
Dublin 7
Miano 7
Ninh Bình 7
Tashkent 7
Vĩnh Long 7
Brasília 6
Carapicuíba 6
Cincinnati 6
Dhaka 6
Guatemala City 6
Guayaquil 6
London 6
Seattle 6
Thái Nguyên 6
Tirana 6
Bogotá 5
Changsha 5
Chennai 5
Curitiba 5
Detroit 5
Doha 5
Istanbul 5
Jeddah 5
Medford 5
Palermo 5
Pasadena 5
Quito 5
San José 5
Thái Bình 5
Acalanes Ridge 4
Belo Horizonte 4
Totale 52.067
Salva come PNG Salva come JPEG
Nome #
High-throughput screening for modulators of ACVR1 transcription: discovery of potential therapeutics for fibrodysplasia ossificans progressiva. 289
Finger motor performance as a new quantitative clinical endpoint in multiple sclerosis 241
Breast cancer incidence after hormonal treatments for infertility: systematic review and meta-analysis of population-based studies 232
A parametric model fitting time to first event for overdispersed data: application to time to relapse in multiple sclerosis. 217
Clinical epidemiology of ALS in Liguria, Italy. 217
Ultrasound versus magnetic resonance imaging for Morton neuroma: systematic review and meta-analysis 208
Evaluation of insulin resistance in a cohort of HIV-infected youth. 207
Adjunct screening with tomosynthesis or ultrasound in women with mammography-negative dense breasts: Interim report of a prospective comparative trial 207
Different MRI patterns in MS worsening after stopping fingolimod 204
Urinary JCV-DNA Testing during Natalizumab Treatment May Increase Accuracy of PML Risk Stratification. 200
Clinical epidemiology of amyotrophic lateral sclerosis in Liguria, Italy: An update of LIGALS register 200
Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: the Italian multi-centre experience. 200
Breast Density Assessment Using a 3T MRI System: Comparison among Different Sequences 193
Use of maraviroc in clinical practice: a multicenter observational study 192
Assessing long-term prognosis improvement as a consequence of treatment pattern changes in MS. 192
The long-term effect of AHSCT on MRI measures of MS evolution: a five-year follow-up study. 189
Can we measure long-term treatment effects in multiple sclerosis? 188
Indirect comparisons of treatment effects in multiple sclerosis. 188
Early onset may predict G101W CDKN2A founder mutation carrier status in Ligurian melanoma patients. 186
Modelling the distribution of cortical lesions in multiple sclerosis. 185
A prospective comparative trial of adjunct screening with tomosynthesis or ultrasound in women with mammography-negative dense breasts (ASTOUND-2) 185
Benefits of glucocorticoids in non-ambulant boys/men with Duchenne muscular dystrophy: A multicentric longitudinal study using the Performance of Upper Limb test 184
Extending the Interval of Natalizumab Dosing: Is Efficacy Preserved? 184
Quantitative assessment of finger motor performance: Normative data 183
Defining the clinical course of multiple sclerosis: the 2013 revisions. 182
The daily diary and the questionnaire are not equivalent for the evaluation of bowel habits. 181
Intense immunosuppression followed by autologous haematopoietic stem cell transplantation as a therapeutic strategy in aggressive forms of multiple sclerosis 181
6 minute walk test in Duchenne MD patients with different mutations: 12 month changes. 181
Remote ischemic postconditioning as a strategy to reduce acute kidney injury during primary PCI: A post-hoc analysis of a randomized trial. 179
99mTc-white cell scanning to detect gut inflammation in children with inflammatory bowel diseases or spondyloarthropathies 178
Impairment in explicit visuomotor sequence learning is related to loss of microstructural integrity of the corpus callosum in multiple sclerosis patients with minimal disability. 178
Pharmacokinetics of Lopinavir Determined with an ELISA Test in Youths with Perinatally Acquired HIV. 178
Risk factors for chronic kidney disease among human immunodeficiency virus-infected patients: A European case control study. 178
Assessment of disease activity in acromegaly by means of a single blood sample: comparison of the 120th minute postglucose value with spontaneous GH secretion and with the IGF system 176
Subclinical motor impairment assessed with an engineered glove correlates with magnetic resonance imaging tissue damage in radiologically isolated syndrome 176
Effect of radiotherapy and chemotherapy on the risk of mucositis during intensity-modulated radiation therapy for oropharyngeal cancer. 175
Intense immunosuppression followed by autologous stem cell transplantation in severe multiple sclerosis. 175
Laparoscopic splenectomy for hematologic diseases: a preliminary analysis performed on the Italian Registry of Laparoscopic Surgery of the Spleen (IRLSS). 175
Functional changes in Duchenne muscular dystrophy: a 12-month longitudinal cohort study. 173
Low intensity lympho-ablative regimen followed by autologous hematopoietic stem cell transplantation in severe forms of multiple sclerosis: A MRI-based clinical study. 173
Effects of hepatitis C virus infection on the pharmacokinetics of ritonavir-boosted atazanavir in HIV-1-infected patients. 173
A T-cell epitope encoded by a subset of HLA-DPB1 alleles determines nonpermissive mismatches for hematologic stem cell transplantation. 172
BCR-ABL nuclear entrapment kills human CML cells: ex-vivo study on 35 patients with the combination of Imatynib Mesylate and Leptomycin B 172
Autologous hematopoietic stem cell transplantation in multiple sclerosis: A phase II trial. 172
Identification of multiple sclerosis patients at highest risk of cognitive impairment using an integrated brain magnetic resonance imaging assessment approach 172
Intra-observer, inter-observer and inter-scanner variations in brain MRI volume measurements in multiple sclerosis 171
Bone quality in perinatally HIV-infected children: role of age, sex, growth, HIV infection, and antiretroviral therapy 169
Modeling the distribution of new MRI cortical lesions in multiple sclerosis longitudinal studies. 169
Bimonthly assessment of magnetization transfer magnetic resonance imaging parameters in multiple sclerosis: a 14-month, multicentre, follow-up study. 169
Treatment decisions in multiple sclerosis - insights from real-world observational studies. 168
A phase I/II study of altered fractionated IMRT alone for intermediate T-stage oropharyngeal carcinoma. 168
Ethics of placebo-controlled clinical trials in multiple sclerosis: a reassessment 167
Optimizing therapy early in multiple sclerosis: An evidence-based view 167
Single-Port Versus Conventional Laparoscopic Cholecystectomy: Better Cosmesis at the Price of an Increased Incisional Hernia Rate? 167
Innovative quantitative testing of hand function in Charcot-Marie-Tooth neuropathy 166
Arginase 2 is expressed by human lung cancer, but it neither induces immune suppression, nor affects disease progression 166
Bone marrow transplantation from unrelated donors: the impact of mismatches with substitutions at position 116 of the human leukocyte antigen class I heavy chain 165
Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis - Clinical implementation in the diagnostic process 165
Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience 165
Abnormal connectivity of the sensorimotor network in patients with MS: a multicenter fMRI study. 164
Body mass index in Th1 and Th2 diseases. 164
Assessing association of comorbidities with treatment choice and persistence in MS: A real-life multicenter study 164
Statistical issues related to the use of MRI data in multiple sclerosis 163
Sexual behaviour in Ligurian (Northern Italy) adolescents and young people: suggestions for HPV vaccination policies 163
Magnetization transfer imaging to monitor the evolution of MS: a 1-year follow-up study 163
Changes in the normal-appearing brain tissue and cognitive impairment in multiple sclerosis 162
Laryngeal long-term morbidity after supraglottic laryngectomy and postoperative radiation therapy 162
The influence of slice orientation on brain MRI lesion load measurement in multiple sclerosis 162
Age-related changes in Conventional, Magnetization Transfer, and Diffusion-Tensor MR Imaging Findings: Study with Whole-Brain Tissue Histogram Analysis. 161
The most frequently asked question to a statistician: The sample size 161
Magnetic resonance imaging as a potential surrogate for relapses in multiple sclerosis: a meta-analytic approach 160
Time to first relapse as an endpoint in multiple sclerosis clinical trials. 160
Clinical baseline factors predict response to natalizumab: their usefulness in patient selection. 160
Improving the characterization of radiologically isolated syndrome suggestive of multiple sclerosis. 160
External validation of unsupervised COVID-19 clinical phenotypes and their prognostic impact 158
A diagnostic score for molecular analysis of hereditary autoinflammatory syndromes with periodic fever in children 158
Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis - Establishing disease prognosis and monitoring patients 158
Long-term impact of interferon or Glatiramer acetate in multiple sclerosis: A systematic review and meta-analysis 158
Approved drugs for multiple sclerosis: The challenge of choice 158
Serum p55 and p75 tumour necrosis factor receptors as markers of disease activity in juvenile chronic arthritis 158
Dosimetric predictors of diarrhea during radiotherapy for prostate cancer. 158
Six minute walk test in type III spinal muscular atrophy: a 12month longitudinal study. 157
MRI measures should be a primary outcome endpoint in Phase III randomized, controlled trials in multiple sclerosis: yes. 157
Sensitivity and reproducibility of volume change measurements of different brain portions on magnetic resonance imaging in patients with multiple sclerosis. 157
A conventional and magnetization transfer MRI study of the cervical cord in patients with multiple sclerosis 156
HER2 status and efficacy of adjuvant anthracyclines in early breast cancer: a pooled analysis of randomized trials 156
Autologous hematopoietic stem cell transplantation in multiple sclerosis: A meta-analysis 156
A Comprehensive Review on Copemyl(®) 156
Clinical activity after fingolimod cessation: Disease reactivation or rebound? 156
Thirteen years of follow-up in patients with adjustable silicone gastric banding for obesity: weight loss and constant rate of late specific complications. 155
A prospective, randomized, controlled trial of autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: a position paper. 155
A brain magnetization transfer MRI study with a clinical follow up of about four years in patients with clinically isolated syndromes suggestive of multiple sclerosis. 155
Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis 155
The distribution of the magnetic resonance imaging response to glatiramer acetate in multiple sclerosis 154
A diffusion tensor MRI study of patients with MCI and AD with a 2-year clinical follow-up 154
Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis 154
Determinants of therapy switch in multiple sclerosis treatment-naïve patients: A real-life study 154
Short-term evolution of individual enhancing MS lesions studied with magnetization transfer imaging 153
Scoring treatment response in patients with relapsing multiple sclerosis. 153
Statistical power of MRI monitored trials in multiple sclerosis: new data and comparison with previous results 152
Totale 17.393
Salva come PNG Salva come JPEG
Categoria #
all - tutte 189.923
article - articoli 188.841
book - libri 0
conference - conferenze 1.082
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 379.846
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021322 0 0 0 0 0 0 0 0 0 0 0 322
2021/20225.124 139 294 581 477 146 361 317 1.214 236 422 299 638
2022/20234.155 462 197 50 416 709 795 19 308 765 58 324 52
2023/20242.426 116 354 57 216 199 513 181 158 145 69 135 283
2024/20256.979 157 607 270 404 944 772 726 953 305 362 620 859
2025/202612.812 1.378 316 855 1.078 1.482 1.358 2.154 621 939 1.370 982 279
Totale 57.623